High Potency Active Pharmaceutical Ingredients (Apis) Market - By Type (Innovative HPAPI, Generic HPAPI) By Manufacturer (Captive HPAPI , Merchant HPAPI ) By Synthesis (Synthetic HPAPI , Biotech HPAPI , moAB, Vaccines) By Therapy (Oncology, Hormonal Disorders, Glaucoma, Other) By Region (North America, Europe, Asia, Rest of the World (RoW)) - Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 185
Status: Published
Report Code: ARI100764
The rising number of biotech & pharmaceutical industry and increasing investments in R&D sector in developing economies such as Asia and Latin America regions are key factors expected to provide growth platform over the forecast period.
Rising incidence of cancer is expected to drive the HPAPI market over the forecast period. Side effects related to chemotherapy such as it also affects non cancerous cells hence targeted therapy approach is gaining popularity as it does not harm non cancerous cells. This is attributed to the rising demand of HPAPI in the future.
The characteristics possessed by these anti-cancerous drugs such as minimum exposure of drug to the non cancerous cell & effectiveness are the factor contributing to the market growth. In addition HPAPI are also used as antibody drug conjugates (ADCs). ADC are the most important & effective treatment in combination with monoclonal antibodies & biologically active drug for the cancer.
The drug’s use for cancer treatment is cytotoxic in nature and is harmful to the non cancerous cells which cause extensive damage to patient’s health. Pharmaceutical industry is facing challenge related to harmful side effects of these drugs on normal cells of the body. While use of less effective drug is ineffective in cancer treatment hence the need for targeted therapy approach came into existence. HPAPI target cancer tissue effectively coupled with minimum exposure of drugs to healthy tissues.
HPAPI are most commonly used in hormonal drugs which are used in treatment of breast cancer. Glaucoma is the other most important type of synthesis of HPAPI. Increasing demand of drugs for the treatment of glaucoma is expected to drive the market growth. The HPAPIs also found type of synthesis in cardiovascular drugs, central nervous system drugs and musculoskeletal drugs.
Increasing demand for these drugs during the forecast period is anticipated to propel the market growth in coming years. In addition, rising usage of HPAPI in gynaecology& cosmetics are accounted for the further growth.
The HPAPI Market is competitive in nature, with several major players competing for market space. Some of the prominent players in this market are Pfizer Inc. (US), Novartis International AG (Switzerland), Merck & Co. (US), Teva Pharmaceutical Industries Ltd. (Israel), Mylan, Inc. (US), BoehringerIngelheim (Germany), Sanofi (France), AbbVie (US), Eli Lilly and Company (US), AstraZeneca plc (UK), Bristol-Myers Squibb (US), and GlaxoSmithKline plc (UK).
Analyst Commentary
The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.
On the basis of type of manufacturer, the captive HPAPI manufacturers segment is expected to account for the largest share of the market. The large share of this segment is attributed to the preference of innovative companies to maintain in-house manufacturing facilities for economic benefits.
On the basis of type of synthesis, the synthetic HPAPI segment is expected to command the largest share in 2018. The increasing emergence of new molecules in the market, rising number of product approvals, technological advancements in synthesis, and ease of production are driving the growth of the synthetic HPAPI segment.
On the basis of therapeutic type of synthesis, oncology segment is expected to account for the largest share of the global market in 2018. The growing incidence and prevalence of cancer across the globe and the launch of new target therapies in addition to technological advancements in the oncology HPAPI-antibody conjugate technology are major factors contributing to the growth of this segment.
Segmentation
The global high potency active pharmaceutical ingredients (APIs) market is segmented based on type, type of synthesis, therapeutic type of synthesis, type of manufacturer and region. On the basis of type of synthesis, the market is categorized into synthetic and biotech HPAPIs. On the basis of type of manufacturer, the market is segmented into captive HPAPI and merchant HPAPI manufacturers.On the basis of therapeutic type of synthesis, the market is segmented into oncology, hormonal imbalance, glaucoma, and other therapeutic type of synthesis. On the basis of type the market is segmented into Innovative HPAPI, Generic HPAPI.
Regional Analysis
North America recorded the largest revenue of the overall industry. The growth is primarily due to the rising chronic disease patients coupled with increasing demand for fast acting and higher efficacy drugs. Furthermore, increasing awareness pertaining to highly potent drugs, rising demand for anti-cancerous therapeutics and growing number of biotechnology industries are the factors attributing to dominant share.
North America have highly regulated and developed pharmaceutical industry. Incidence of cancer is higher, in this region hence, cancer therapy drugs show lucrative growth and is expected to be the same during the future period. Increasing incidence of older age diseases with changing lifestyle are the key contributing factors for growing demand for HPAPIs in this region.
The U.S. held the dominant market share of high potency APIs in North America. The key industry players holding majority of market share in this region are SAFC, Teva Pharmaceuticals, Bristol Myers Squibb, Cambrex Ferro, and Carbogen Amcis.
Asia Pacific region is expected to register high growth owing to the flourishing generic drug market, developing healthcare infrastructure and presence of untapped opportunities. Growing investments in biotechnology sector, supportive government initiatives and rapidly growing oncology market are the factors expected to propel the industry growth in this region.
In addition, growing generic sector business and improving healthcare facilities is anticipating the further growth in the near future. Healthcare infrastructure is growing rapidly in Asian countries, especially in India & China. The demand for oncology drugs & is expected to fuel the market growth over the forecast period.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact on High Potency Active Pharmaceutical Ingredients Market
Chapter 5. Global High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 – 2027 (USD Billion)
5.1. Global High Potency Active Pharmaceutical Ingredients Market Share, By Type, 2020 & 2027 (%)
5.1.1. Innovative HPAPI
5.1.1.1. Market Size and Projections, 2015 – 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
5.1.2. Generic HPAPI
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 6. Global High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 – 2027 (USD Billion)
6.1. Global High Potency Active Pharmaceutical Ingredients Market Share, By Manufacturer, 2020 & 2027 (%)
6.1.1. Captive HPAPI
6.1.1.1. Market Size and Projections, 2015 – 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
6.1.2. Merchant HPAPI
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 7. Global High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 – 2027 (USD Billion)
7.1. Global High Potency Active Pharmaceutical Ingredients Market Share, By Synthesis, 2020 & 2027 (%)
7.1.1. Synthetic HPAPI
7.1.1.1. Market Size and Projections, 2015 – 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.2. Biotech HPAPI
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.3. moAB
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
7.1.4. Vaccines
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 8. Global High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 – 2027 (USD Billion)
8.1. Global High Potency Active Pharmaceutical Ingredients Market Share, By Therapy, 2020 & 2027 (%)
8.1.1. Oncology
8.1.1.1. Market Size and Projections,2015 – 2027 (USD Billion)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.2. Hormonal Disorders
8.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.3. Glaucoma
8.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
8.1.4. Other
8.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
8.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Billion)
Chapter 9. Global High Potency Active Pharmaceutical Ingredients Market Overview, By Geography, 2015 - 2027 (USD Billion)
9.1. Global High Potency Active Pharmaceutical Ingredients Market Share, By Geography, 2015 - 2027(USD Billion)
9.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 10. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. North America High Potency Active Pharmaceutical Ingredients Market Overview, 2020 & 2027 (%)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.3. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
10.1.4. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
10.1.5. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
10.1.6. North America High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.6.1. U.S. High Potency Active Pharmaceutical Ingredients Market Overview, 2015 - 2027 (USD Billion)
10.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.1.2. U.S. High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.6.1.3. U.S. High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027 (USD Billion)
10.1.6.1.4. U.S. High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027 (USD Billion)
10.1.6.1.5. U.S. High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027 (USD Billion)
10.1.6.2. Canada High Potency Active Pharmaceutical Ingredients Market Overview, 2015 - 2027 (USD Billion)
10.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.2.2. Canada High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.6.2.3. Canada High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027 (USD Billion)
10.1.6.2.4. Canada High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027 (USD Billion)
10.1.6.2.5. Canada High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027 (USD Billion)
10.1.6.3. Mexico High Potency Active Pharmaceutical Ingredients Market Overview, 2015 - 2027 (USD Billion)
10.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.6.3.2. Mexico High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.6.3.3. Mexico High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027 (USD Billion)
10.1.6.3.4. Mexico High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027 (USD Billion)
10.1.6.3.5. Mexico High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027 (USD Billion)
Chapter 11. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
11.1. Europe High Potency Active Pharmaceutical Ingredients Market Overview, 2020 & 2027 (%)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.3. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027 (USD Billion)
11.1.4. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027 (USD Billion)
11.1.5. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027 (USD Billion)
11.1.6. Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.6.1. Germany
11.1.6.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.1.2. Germany High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.6.1.3. Germany High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027 (USD Billion)
11.1.6.1.4. Germany High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027 (USD Billion)
11.1.6.1.5. Germany High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027 (USD Billion)
11.1.6.1.6. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.1.7. France High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.6.1.8. France High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
11.1.6.1.9. France High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
11.1.6.1.10. France High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
11.1.6.2. UK
11.1.6.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.2.2. UK High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.6.2.3. UK High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
11.1.6.2.4. UK High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
11.1.6.2.5. UK High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
11.1.6.3. Italy
11.1.6.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.3.2. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.6.3.3. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
11.1.6.3.4. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
11.1.6.3.5. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
11.1.6.4. Spain
11.1.6.4.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.6.4.2. Spain High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.6.4.3. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
11.1.6.4.4. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
11.1.6.4.5. Italy High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
11.1.6.5. Rest of Europe
11.1.6.5.1. Market size and projections, 2015 – 2025
11.1.6.5.2. Rest of Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.6.5.3. Rest of Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
11.1.6.5.4. Rest of Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
11.1.6.5.5. Rest of Europe High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
Chapter 12. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, 2020 & 2027(%)
12.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.2. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.3. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.4. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.5. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
12.1.6. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
12.1.6.1. India
12.1.6.1.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.1.2. India High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.6.1.3. India High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.6.1.4. India High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.6.1.5. India High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
12.1.6.2. China
12.1.6.2.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.2.2. China High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.6.2.3. China High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.6.2.4. China High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.6.2.5. China High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
12.1.6.3. Japan
12.1.6.3.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.3.2. Japan High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.6.3.3. Japan High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.6.3.4. Japan High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.6.3.5. Japan High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
12.1.6.4. South Korea
12.1.6.4.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.4.2. South Korea High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.6.4.3. South Korea High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.6.4.4. South Korea High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.6.4.5. South Korea High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market size and projections, 2015 - 2027(USD Billion)
12.1.6.5.2. Rest of Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
12.1.6.5.3. Rest of Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
12.1.6.5.4. Rest of Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
12.1.6.5.5. Rest of Asia Pacific High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
Chapter 13. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
13.1. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, 2015 - 2027(USD Billion)
13.1.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.2. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.3. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
13.1.4. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
13.1.5. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
13.1.6. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
13.1.6.1. GCC
13.1.6.1.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.1.2. GCC High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.6.1.3. GCC High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
13.1.6.1.4. GCC High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
13.1.6.1.5. GCC High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
13.1.6.2. South Africa
13.1.6.2.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.2.2. South Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.6.2.3. South Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
13.1.6.2.4. South Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
13.1.6.2.5. South Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market size and projections, 2015 - 2027(USD Billion)
13.1.6.3.2. Rest of Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
13.1.6.3.3. Rest of Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
13.1.6.3.4. Rest of Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
13.1.6.3.5. Rest of Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
Chapter 14. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015 - 2027(USD Billion)
14.1. South America High Potency Active Pharmaceutical Ingredients Market Overview, 2015 - 2027(USD Billion)
14.1.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.2. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Type 2015 - 2027(USD Billion)
14.1.3. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer 2015 - 2027(USD Billion)
14.1.4. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis 2015 - 2027(USD Billion)
14.1.5. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy 2015 - 2027(USD Billion)
14.1.6. South America High Potency Active Pharmaceutical Ingredients Market Overview, By Countries, 2015- 2026(USD Billion)
14.1.7. Brazil
14.1.7.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.7.2. Brazil High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
14.1.7.3. Brazil High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
14.1.7.4. Brazil High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
14.1.7.5. Brazil High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
14.1.8. Argentina
14.1.8.1. Market size and projections, 2015 - 2027(USD Billion)
14.1.8.2. Argentina High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
14.1.8.3. Argentina High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
14.1.8.4. Argentina High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
14.1.8.5. Argentina High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
14.1.9. Rest of South America
14.1.9.1. Market size and projections, 2015 – 2027
14.1.9.2. Rest of South America High Potency Active Pharmaceutical Ingredients Market Overview, By Type, 2015 - 2027(USD Billion)
14.1.9.3. Rest of South America High Potency Active Pharmaceutical Ingredients Market Overview, By Manufacturer, 2015 - 2027(USD Billion)
14.1.9.4. Rest of South America High Potency Active Pharmaceutical Ingredients Market Overview, By Synthesis, 2015 - 2027(USD Billion)
14.1.9.5. Rest of South America High Potency Active Pharmaceutical Ingredients Market Overview, By Therapy, 2015 - 2027(USD Billion)
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New product development
Chapter 16. Key Vendor Analysis
16.1. Merck & Co
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Product Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. Sanofi
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Product Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Teva Pharmaceutical Industries Ltd
16.4. Novartis International AG
16.5. AbbVie
16.6. Others
Chapter 17. High Potency Active Pharmaceutical Ingredients Market Cost Analysis
17.1. Key Raw Materials Analysis
17.1.1. Key Raw Materials
17.1.2. Price Trend of Key Raw Materials
17.1.3. Key Suppliers of Raw Materials
17.1.4. Market Concentration Rate of Raw Materials
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. High Potency Active Pharmaceutical Ingredients Market Industrial Chain Analysis
18.2. Upstream Raw Materials Sourcing
18.3. Raw Materials Sources of High Potency Active Pharmaceutical Ingredients Major Manufacturers in 2020
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Industry
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global High Potency Active Pharmaceutical Ingredients Market share, By Type, 2020 & 2027 (%)
10. Global High Potency Active Pharmaceutical Ingredients Market, by Innovative HPAPI, By Type, 2015 - 2027(USD Billion)
11. Global High Potency Active Pharmaceutical Ingredients Market, by Generic HPAPI, By Type, 2015 - 2027(USD Billion)
12. Global High Potency Active Pharmaceutical Ingredients Market share, By Manufacturer, 2020 & 2027 (%)
13. Global High Potency Active Pharmaceutical Ingredients Market, by Captive HPAPI, By Manufacturer, 2015 - 2027(USD Billion)
14. Global High Potency Active Pharmaceutical Ingredients Market, by Merchant HPAPI, By Manufacturer, 2015 - 2027(USD Billion)
15. Global High Potency Active Pharmaceutical Ingredients Market share, By Synthesis, 2020 & 2027 (%)
16. Global High Potency Active Pharmaceutical Ingredients Market, by Synthetic HPAPI, By Synthesis, 2015 - 2027(USD Billion)
17. Global High Potency Active Pharmaceutical Ingredients Market, by Biotech HPAPI, By Synthesis, 2015 - 2027(USD Billion)
18. Global High Potency Active Pharmaceutical Ingredients Market, by moAB, By Synthesis, 2015 - 2027(USD Billion)
19. Global High Potency Active Pharmaceutical Ingredients Market, by Vaccines, By Synthesis, 2015 - 2027(USD Billion)
20. Global High Potency Active Pharmaceutical Ingredients Market share, By Therapy, 2020 & 2027 (%)
21. Global High Potency Active Pharmaceutical Ingredients Market, by Oncology, By Therapy, 2015 - 2027(USD Billion)
22. Global High Potency Active Pharmaceutical Ingredients Market, by Hormonal Disorders, By Therapy, 2015 - 2027(USD Billion)
23. Global High Potency Active Pharmaceutical Ingredients Market, by Glaucoma, By Therapy, 2015 - 2027(USD Billion)
24. Global High Potency Active Pharmaceutical Ingredients Market, by Others, By Therapy, 2015 - 2027(USD Billion)
25. Global High Potency Active Pharmaceutical Ingredients Market share, by region, 2020 & 2027 (%)
26. North America High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
27. North America High Potency Active Pharmaceutical Ingredients Market share, by Countries, 2020 & 2027 (%)
28. U.S. High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
29. Canada High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
30. Europe High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
31. Europe High Potency Active Pharmaceutical Ingredients Market share, by Countries, 2020 & 2027 (%)
32. Spain High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
33. UK High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
34. Italy High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
35. Germany High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
36. France High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
37. Rest of Europe High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
38. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
39. Asia-Pacific High Potency Active Pharmaceutical Ingredients Market share, by Countries, 2020 & 2027 (%)
40. China High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
41. India High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
42. Australia High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
43. Japan High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
44. Rest of Asia-Pacific High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
45. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
46. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market share, by Countries, 2020 & 2027 (%)
47. GCC High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
48. South Africa High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
49. Rest Of Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
50. South America High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
51. Brazil High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
52. Mexico High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
53. Argentina High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
54. Rest of South America High Potency Active Pharmaceutical Ingredients Market, 2020 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global High Potency Active Pharmaceutical Ingredients Market, 2015-2027(USD Billion)
4. Global High Potency Active Pharmaceutical Ingredients Market requirement, by country, 2015-2027,(USD Billion)
5. North America High Potency Active Pharmaceutical Ingredients Market, By Type, 2015-2027(USD Billion)
6. North America High Potency Active Pharmaceutical Ingredients Market, By Manufacturer, 2015-2027(USD Billion)
7. North America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, 2015-2027(USD Billion)
8. North America High Potency Active Pharmaceutical Ingredients Market, By Therapy, 2015-2027(USD Billion)
9. Europe High Potency Active Pharmaceutical Ingredients Market, By Type, 2015-2027(USD Billion)
10. Europe High Potency Active Pharmaceutical Ingredients Market, By Manufacturer, 2015-2027(USD Billion)
11. Europe High Potency Active Pharmaceutical Ingredients Market, By Synthesis, 2015-2027(USD Billion)
12. Europe High Potency Active Pharmaceutical Ingredients Market, By Therapy, 2015-2027(USD Billion)
13. Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Type, 2015-2027(USD Billion)
14. Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Manufacturer, 2015-2027(USD Billion)
15. Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Synthesis, 2015-2027(USD Billion)
16. Asia Pacific High Potency Active Pharmaceutical Ingredients Market, By Therapy, 2015-2027(USD Billion)
17. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Type, 2015-2027(USD Billion)
18. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Manufacturer, 2015-2027(USD Billion)
19. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Synthesis, 2015-2027(USD Billion)
20. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market, By Therapy, 2015-2027(USD Billion)
21. South America High Potency Active Pharmaceutical Ingredients Market, By Type, 2015-2027(USD Billion)
22. South America High Potency Active Pharmaceutical Ingredients Market, By Manufacturer, 2015-2027(USD Billion)
23. South America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, 2015-2027(USD Billion)
24. South America High Potency Active Pharmaceutical Ingredients Market, By Therapy, 2015-2027(USD Billion)
25. Global High Potency Active Pharmaceutical Ingredients Market, Company Market Share, 2020 (%)
26. Merck & Co: Product Benchmarking
27. Merck & Co: Financial Performance
28. Sanofi: Product Benchmarking
29. Sanofi: Financial Performance
30. Teva Pharmaceutical Industries Ltd: Product Benchmarking
31. Teva Pharmaceutical Industries Ltd: Financial Performance
32. Novartis International AG: Product Benchmarking
33. Novartis International AG: Financial Performance
34. AbbVie: Product Benchmarking
35. AbbVie: Financial Performance
The Leading Key Players in High Potency Active Pharmaceutical Ingredients Market Market
Pfizer Inc. (US)
Novartis International AG (Switzerland)
Merck & Co. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Mylan Inc. (US)
BoehringerIngelheim (Germany)
Sanofi (France)
AbbVie (US)
Eli Lilly and Company (US)
AstraZeneca plc (UK)
Bristol-Myers Squibb (US)
GlaxoSmithKline plc (UK).
